Mantara Inc
Pharmacogenomic DNA test kit for predicting drug side effects based on genetic variants
- Sector
- Medtech
- Headquarters
- Jersey City, NJ
- Founded
- 2005
- Latest Form D
- $17.4M, Jul 2012
- Total capital
- $22.4M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $22.4M
- 2 Form D · last Jul 2012
- 171 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- None on recordNo USPTO grants. Applications publish after 18 months.
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 2nd filing$17.4M
- Private capital raisedForm D · SEC · 1st filing$5M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Founders and team
From SEC Form D filings- Allen & Buckeridge Asset Management Limited (as responsible entity for the Allen & Buckeridge Emerging Technologies Fund, A&B ETCP, L.P.)PromoterNamed in SEC Form D filings
- Bill Segal (as trustee for BRAT Family Trust)PromoterNamed in SEC Form D filings
- Bill Segal *as trustee for BRAT Family Trust)PromoterNamed in SEC Form D filings
- Bruce FramDirectorNamed in SEC Form D filings
- Charles SusiDirectorNamed in SEC Form D filings
- CM Capital Investements Pty Ltd (in its capacity as manager of the CM Capital Venture Trust No. 3 and as trustee of CM Capital 3A)PromoterNamed in SEC Form D filings
Show all 22 people
- CM Capital Investments Pty Ltd (in its capacity as manager of the CM Capital Venture Trust No. 3 and as trustee of CM Capital 3A)PromoterNamed in SEC Form D filings
- David GilbertExecutive Officer, DirectorNamed in SEC Form D filings
- David & Louise Arnold (as trustees for Gough Arnold Trust 30 943 402 322)PromoterNamed in SEC Form D filings
- Gerard Von DohlenDirectorNamed in SEC Form D filings
- James SmithDirectorNamed in SEC Form D filings
- John PowerExecutive OfficerNamed in SEC Form D filings
- Matt SenecalDirectorNamed in SEC Form D filings
- MDV VII, L.P., as nominee for MDV VII, L.P., MDV VII Leaders' Fund, L.P., MDV ENF VII(A), L.P. and MDV ENF VII(B), L.P.PromoterNamed in SEC Form D filings
- Meghan LyonsExecutive Officer, DirectorNamed in SEC Form D filings
- Michael BegunDirectorNamed in SEC Form D filings
- Michael ChinExecutive Officer, DirectorNamed in SEC Form D filings
- Richard SchenkmanDirectorNamed in SEC Form D filings
- Robert ChristiansenDirectorNamed in SEC Form D filings
- Robert DiFazioDirectorNamed in SEC Form D filings
- Shawn SlovesExecutive OfficerNamed in SEC Form D filings
- Southern Cross Venture Partners/Management Pty LtdPromoterNamed in SEC Form D filings
What it has protected
No granted patents are on record.
USPTO usually publishes applications 18 months after filing, so recent applications may not be visible yet. Patents assigned under a different entity name won’t match.
Checked: USPTO granted patents and published applications · Oct 23, 2026
Related companies, and why
- Noxilizer IncSimilar federal contract value in Medtech · null in contracts
- PARADIGM SPINE LLCSimilar federal contract value in Medtech · null in contracts
- AIRXPANDERS INCSimilar federal contract value in Medtech · null in contracts
- SciLogica CorpSimilar federal contract value in Medtech · null in contracts
- Microbix Biosystems Inc.Similar federal contract value in Medtech · null in contracts
- VERAX BIOMEDICAL INCSimilar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .